46 related articles for article (PubMed ID: 19692825)
1. Unexpected I-123 FP-CIT uptake in a brain tumor.
Boronat-Ferrater M; Lorenzo-Bosquet C; León A; Aguadé-Bruix S; Rossi-Seoane S; Hernández-Vara J; Alvarez-Sabín J; Rovira A; Castell-Conesa J
Clin Nucl Med; 2009 Sep; 34(9):608-9. PubMed ID: 19692825
[TBL] [Abstract][Full Text] [Related]
2. Unexpected finding on I-123 FP-CIT SPECT leading to the diagnosis of cerebral meningioma.
Biancheri-Mounicq I; Colombié M; Pin JC; Lecoanet A; Adam-Tariel F
Clin Nucl Med; 2011 Feb; 36(2):156-7. PubMed ID: 21220989
[TBL] [Abstract][Full Text] [Related]
3. The incidental suggestive meningioma presenting as high 18F FP-CIT uptake on PET/CT study.
Song IU; Lee SH; Chung YA
Clin Nucl Med; 2014 Jan; 39(1):e97-8. PubMed ID: 23877508
[TBL] [Abstract][Full Text] [Related]
4. Brain parenchyma sonography and 123I-FP-CIT SPECT in Parkinson's disease and essential tremor.
Doepp F; Plotkin M; Siegel L; Kivi A; Gruber D; Lobsien E; Kupsch A; Schreiber SJ
Mov Disord; 2008 Feb; 23(3):405-10. PubMed ID: 18067184
[TBL] [Abstract][Full Text] [Related]
5. Findings of cerebral metastasis demonstrated on Tc-99m TRODAT-1 SPECT.
Wu YC; Hsieh TC; Sun SS; Yen KY; Wang CH; Lin YY; Kao CH
Clin Nucl Med; 2010 Feb; 35(2):107-8. PubMed ID: 20090460
[No Abstract] [Full Text] [Related]
6. Clinical impact of correlative [123I]-FP-CIT brain imaging and neurological findings in suspect Parkinson's disease.
Covelli EM; Brunetti A; Di Lauro A; Sullo P; Mazzarella G; Tedeschi E; Belfiore G
Radiol Med; 2004 Oct; 108(4):417-25. PubMed ID: 15525895
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of 123I-FP-CIT SPECT in the differential diagnosis of essential tremor and Parkinson's disease in Italy.
Antonini A; Berto P; Lopatriello S; Tamma F; Annemans L; Chambers M
Mov Disord; 2008 Nov; 23(15):2202-9. PubMed ID: 18785639
[TBL] [Abstract][Full Text] [Related]
8. Differences in nigro-striatal impairment in clinical variants of early Parkinson's disease: evidence from a FP-CIT SPECT study.
Rossi C; Frosini D; Volterrani D; De Feo P; Unti E; Nicoletti V; Kiferle L; Bonuccelli U; Ceravolo R
Eur J Neurol; 2010 Apr; 17(4):626-30. PubMed ID: 20050904
[TBL] [Abstract][Full Text] [Related]
9. [123I]FP-CIT binds to the dopamine transporter as assessed by biodistribution studies in rats and SPECT studies in MPTP-lesioned monkeys.
Booij J; Andringa G; Rijks LJ; Vermeulen RJ; De Bruin K; Boer GJ; Janssen AG; Van Royen EA
Synapse; 1997 Nov; 27(3):183-90. PubMed ID: 9329154
[TBL] [Abstract][Full Text] [Related]
10. Different patterns of nigrostriatal degeneration in tremor type versus the akinetic-rigid and mixed types of Parkinson's disease at the early stages: molecular imaging with 123I-FP-CIT SPECT.
Schillaci O; Chiaravalloti A; Pierantozzi M; Di Pietro B; Koch G; Bruni C; Stanzione P; Stefani A
Int J Mol Med; 2011 Nov; 28(5):881-6. PubMed ID: 21811760
[TBL] [Abstract][Full Text] [Related]
11. [123I] FP-CIT spect study in vascular parkinsonism and Parkinson's disease.
Zijlmans J; Evans A; Fontes F; Katzenschlager R; Gacinovic S; Lees AJ; Costa D
Mov Disord; 2007 Jul; 22(9):1278-85. PubMed ID: 17486613
[TBL] [Abstract][Full Text] [Related]
12. Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group.
Benamer TS; Patterson J; Grosset DG; Booij J; de Bruin K; van Royen E; Speelman JD; Horstink MH; Sips HJ; Dierckx RA; Versijpt J; Decoo D; Van Der Linden C; Hadley DM; Doder M; Lees AJ; Costa DC; Gacinovic S; Oertel WH; Pogarell O; Hoeffken H; Joseph K; Tatsch K; Schwarz J; Ries V
Mov Disord; 2000 May; 15(3):503-10. PubMed ID: 10830416
[TBL] [Abstract][Full Text] [Related]
13. Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson's disease.
Booij J; Habraken JB; Bergmans P; Tissingh G; Winogrodzka A; Wolters EC; Janssen AG; Stoof JC; van Royen EA
J Nucl Med; 1998 Nov; 39(11):1879-84. PubMed ID: 9829575
[TBL] [Abstract][Full Text] [Related]
14. Iodine-123-N-omega-fluoropropyl-2beta-carbomethoxy-3beta-(4-iod ophenyl)tropane SPECT in healthy controls and early-stage, drug-naive Parkinson's disease.
Tissingh G; Booij J; Bergmans P; Winogrodzka A; Janssen AG; van Royen EA; Stoof JC; Wolters EC
J Nucl Med; 1998 Jul; 39(7):1143-8. PubMed ID: 9669384
[TBL] [Abstract][Full Text] [Related]
15. Dual-radionuclide brain SPECT for the differential diagnosis of parkinsonism.
El Fakhri G; Ouyang J
Methods Mol Biol; 2011; 680():237-46. PubMed ID: 21153385
[TBL] [Abstract][Full Text] [Related]
16. Investigating dopaminergic neurotransmission with 123I-FP-CIT SPECT: comparability of modern SPECT systems.
Meyer PT; Sattler B; Lincke T; Seese A; Sabri O
J Nucl Med; 2003 May; 44(5):839-45. PubMed ID: 12732687
[TBL] [Abstract][Full Text] [Related]
17. Dopaminergic deficit is not the rule in orthostatic tremor.
Trocello JM; Zanotti-Fregonara P; Roze E; Apartis E; Legrand AP; Habert MO; Devaux JY; Vidailhet M
Mov Disord; 2008 Sep; 23(12):1733-8. PubMed ID: 18661569
[TBL] [Abstract][Full Text] [Related]
18. FP-CIT and MIBG scintigraphy in early Parkinson's disease.
Spiegel J; Möllers MO; Jost WH; Fuss G; Samnick S; Dillmann U; Becker G; Kirsch CM
Mov Disord; 2005 May; 20(5):552-61. PubMed ID: 15645531
[TBL] [Abstract][Full Text] [Related]
19. Prospective study of presynaptic dopaminergic imaging in patients with mild parkinsonism and tremor disorders: part 1. Baseline and 3-month observations.
Benamer HT; Oertel WH; Patterson J; Hadley DM; Pogarell O; Höffken H; Gerstner A; Grosset DG
Mov Disord; 2003 Sep; 18(9):977-84. PubMed ID: 14502664
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of brain tumor recurrence by (99m)Tc-tetrofosmin SPECT: a prospective pilot study.
Alexiou GA; Fotopoulos AD; Papadopoulos A; Kyritsis AP; Polyzoidis KS; Tsiouris S
Ann Nucl Med; 2007 Jul; 21(5):293-8. PubMed ID: 17634847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
